Erythematotelangiectatic rosacea presents as persistent
erythema and
telangiectasia with frequent
flushing and blushing on the facial and extrafacial skin. Additionally,
papulopustular rosacea shows acneiform papules, pustules, and nodules with persistent plaque-form
edema. Despite garnering only grade-C or -D level recommendations, a 585-nm or 595-nm flashlamp-pumped
pulsed-dye laser can be considered as an effective therapeutic modality for the treatment of
rosacea in patients who are refractory to topical and/or systemic treatments. In this report, treatment with a Q-switched 595-nm
neodymium-doped
yttrium aluminum garnet (
Nd:YAG) laser with low non-purpuragenic fluence proved to be safe and effective in treating early-stage
erythematotelangiectatic rosacea in two female Korean patients.
Laser treatment for
rosacea was delivered with the settings of pulse energy of 0.4-0.5 J/cm(2), pulse duration of 5-10 ns, 5-mm spot size, 5 Hz, and 500 shots. Additionally, we found that remarkable
therapeutic effects were achieved for both
rosacea and
melasma by combining Q-switched quick pulse-to-pulse 1,064-nm Nd:YAG and Q-switched 595-nm
Nd:YAG laser treatments, which required only the changing of handpieces equipped with solid
dye. In conclusion, we suggest that treatment with a Q-switched 595-nm
Nd:YAG laser with low fluence may provide an additional therapeutic option for treating early-stage
erythematotelangiectatic rosacea.